Company Filing History:
Years Active: 2005
Title: Helmut Fiebig: Innovator in Allergen Immunotherapy
Introduction
Helmut Fiebig is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of allergen immunotherapy, particularly through his innovative research and patents. His work focuses on developing modified recombinant allergens that can improve the treatment of pollen allergies.
Latest Patents
Helmut Fiebig holds a patent titled "Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same." This invention relates to modified recombinant allergen mutants derived from natural raw materials, such as pollen from specific grass species. These modified allergens stimulate lymphocytes from allergic patients to proliferate and synthesize cytokines. However, they exhibit a significantly reduced ability to bind to IgE antibodies present in the serum of T lymphocyte donors. This characteristic allows for a more targeted and effective allergy therapy.
Career Highlights
Fiebig is associated with Merck Patent Gesellschaft MIT, where he has been instrumental in advancing research in allergen immunotherapy. His work has paved the way for new treatment options for individuals suffering from pollen allergies. His innovative approach has garnered attention in the scientific community and has the potential to improve the quality of life for many allergy sufferers.
Collaborations
Helmut Fiebig has collaborated with notable colleagues, including Helga Kahlert and Hans-Thomas Stüwe. These collaborations have contributed to the development and refinement of his patented technologies.
Conclusion
Helmut Fiebig's contributions to allergen immunotherapy through his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of targeted allergy treatments, showcasing the importance of innovation in medical science.